Literature DB >> 9284665

Cognitive impairment in elderly people: population based estimate of the future in England, Scotland, and Wales.

D Melzer1, M Ely, C Brayne.   

Abstract

Entities:  

Mesh:

Year:  1997        PMID: 9284665      PMCID: PMC2127304          DOI: 10.1136/bmj.315.7106.462

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  13 in total

Review 1.  Bringing prevention in geriatrics: evidences from cardiovascular medicine supporting the new challenge.

Authors:  Angelo Scuteri; Edward G Lakatta
Journal:  Exp Gerontol       Date:  2012-03-03       Impact factor: 4.032

2.  Profile of disability in elderly people: estimates from a longitudinal population study.

Authors:  D Melzer; B McWilliams; C Brayne; T Johnson; J Bond
Journal:  BMJ       Date:  1999-04-24

3.  High caloric intake, poor cognition and dementia: the Caerphilly Prospective Study.

Authors:  Samuel Thomas Creavin; John Gallacher; Janet Pickering; Ann Fehily; Mark Fish; Shah Ebrahim; Antony Bayer; Yoav Ben-Shlomo
Journal:  Eur J Epidemiol       Date:  2012-03-06       Impact factor: 8.082

Review 4.  Antioxidant nutrients and age-related cognitive decline: a systematic review of population-based cohort studies.

Authors:  Snorri Bjorn Rafnsson; Vardis Dilis; Antonia Trichopoulou
Journal:  Eur J Nutr       Date:  2013-06-07       Impact factor: 5.614

Review 5.  Stroke, dementia, and drug delivery.

Authors:  G A Ford; C A Bryant; A A Mangoni; S H D Jackson
Journal:  Br J Clin Pharmacol       Date:  2004-01       Impact factor: 4.335

6.  Can lifestyle modification improve neurocognition? Rationale and design of the ENLIGHTEN clinical trial.

Authors:  James A Blumenthal; Patrick J Smith; Kathleen Welsh-Bohmer; Michael A Babyak; Jeffrey Browndyke; Pao-Hwa Lin; P Murali Doraiswamy; James Burke; William Kraus; Alan Hinderliter; Andrew Sherwood
Journal:  Contemp Clin Trials       Date:  2012-09-19       Impact factor: 2.226

7.  A randomised controlled trial investigating the effect of n-3 long-chain polyunsaturated fatty acid supplementation on cognitive and retinal function in cognitively healthy older people: the Older People And n-3 Long-chain polyunsaturated fatty acids (OPAL) study protocol [ISRCTN72331636].

Authors:  Alan D Dangour; Felicity Clemens; Diana Elbourne; Nicky Fasey; Astrid E Fletcher; Pollyanna Hardy; Graham E Holder; Felicia A Huppert; Rosemary Knight; Louise Letley; Marcus Richards; Ann Truesdale; Madge Vickers; Ricardo Uauy
Journal:  Nutr J       Date:  2006-08-31       Impact factor: 3.271

8.  Screening for antimalarial and acetylcholinesterase inhibitory activities of some Iranian seaweeds.

Authors:  A Ghannadi; A Plubrukarn; K Zandi; K Sartavi; A Yegdaneh
Journal:  Res Pharm Sci       Date:  2013-04

9.  Hypertension and cognitive decline: impact on executive function.

Authors:  Augusto Vicario; Carlos D Martinez; Dolores Baretto; Alejandra Diaz Casale; Liliana Nicolosi
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-10       Impact factor: 3.738

10.  Dementia in Down's syndrome: an MRI comparison with Alzheimer's disease in the general population.

Authors:  Diane Mullins; Eileen Daly; Andrew Simmons; Felix Beacher; Catherine Ml Foy; Simon Lovestone; Brian Hallahan; Kieran C Murphy; Declan G Murphy
Journal:  J Neurodev Disord       Date:  2013-08-20       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.